Marine Drugs (Dec 2020)

Identification and Characterization of a New Type III Polyketide Synthase from a Marine Yeast, <i>Naganishia uzbekistanensis</i>

  • Laure Martinelli,
  • Vanessa Redou,
  • Bastien Cochereau,
  • Ludovic Delage,
  • Nolwenn Hymery,
  • Elisabeth Poirier,
  • Christophe Le Meur,
  • Gaetan Le Foch,
  • Lionel Cladiere,
  • Mohamed Mehiri,
  • Nathalie Demont-Caulet,
  • Laurence Meslet-Cladiere

DOI
https://doi.org/10.3390/md18120637
Journal volume & issue
Vol. 18, no. 12
p. 637

Abstract

Read online

A putative Type III Polyketide synthase (PKSIII) encoding gene was identified from a marine yeast, Naganishia uzbekistanensis strain Mo29 (UBOCC-A-208024) (formerly named as Cryptococcus sp.) isolated from deep-sea hydrothermal vents. This gene is part of a distinct phylogenetic branch compared to all known terrestrial fungal sequences. This new gene encodes a C-terminus extension of 74 amino acids compared to other known PKSIII proteins like Neurospora crassa. Full-length and reduced versions of this PKSIII were successfully cloned and overexpressed in a bacterial host, Escherichia coli BL21 (DE3). Both proteins showed the same activity, suggesting that additional amino acid residues at the C-terminus are probably not required for biochemical functions. We demonstrated by LC-ESI-MS/MS that these two recombinant PKSIII proteins could only produce tri- and tetraketide pyrones and alkylresorcinols using only long fatty acid chain from C8 to C16 acyl-CoAs as starter units, in presence of malonyl-CoA. In addition, we showed that some of these molecules exhibit cytotoxic activities against several cancer cell lines.

Keywords